Coty Stock Plunges Over 20% After Cosmetics Maker Reports Surprise Loss

Coty (COTY) reported an unexpected fiscal fourth-quarter net loss of $72.1 million, or an adjusted $0.05 per share, missing analyst expectations for a profit, with like-for-like sales declining 9% year-over-year. The cosmetics maker attributed the underperformance to cautious retailer ordering, U.S. demand softness, and broader macroeconomic and tariff uncertainties, projecting further like-for-like sales declines of 6-8% in the current quarter and 3-5% in Q2 before an anticipated recovery in the second half of the fiscal year. Following the weak results and guidance, Coty shares plunged nearly 22%, reflecting significant investor concern over its near-term outlook.

Analysis

Coty's fiscal fourth-quarter results revealed a significant deterioration in its operational performance and outlook, triggering a severe market repricing. The company reported an unexpected net loss of $72.1 million, or an adjusted loss of $0.05 per share, a stark miss against consensus expectations for a $0.01 profit. This was compounded by a 9% year-over-year decline in like-for-like sales, which management attributed to cautious ordering from retailers, softening U.S. consumer demand, and a more promotional competitive landscape. The forward guidance is particularly alarming, with the company projecting continued like-for-like sales declines of 6-8% in the current quarter and 3-5% in the subsequent quarter. While management anticipates a return to growth in the second half of the fiscal year, the near-term weakness points to at least six months of significant headwinds. The market's reaction, a nearly 22% single-day stock price decline that brought year-to-date losses to almost 50%, underscores deep investor concern over the company's ability to navigate macroeconomic pressures and achieve its guided H2 recovery.

Key Decisions for Investors

• Given the deeply negative forward guidance for the next two quarters and significant downward price momentum, investors should exercise extreme caution, as the path to the guided second-half recovery is fraught with execution risk.
• Monitor key performance indicators such as retailer inventory levels and U.S. consumer spending on mass cosmetics to independently verify the timing and strength of any potential turnaround before considering a long position.
• For those considering a contrarian play based on the stock's 50% year-to-date plunge, it is critical to weigh the potential for a value trap against the promised, but highly uncertain, second-half recovery.